Ex vivo engineering of phagocytic signals in breast cancer cells for a whole tumor cell-based vaccine
Abstract Background Today, cell therapies are constantly evolving and providing new options for cancer patients. These therapies are mostly based on the inoculation of immune cells extracted from a person’s own tumor; however, some studies using whole tumor cell-based vaccines are approaching the le...
Saved in:
| Main Authors: | Román Martí-Díaz, Luis Sánchez-del-Campo, María F. Montenegro, Trinidad Hernández-Caselles, Antonio Piñero-Madrona, Juan Cabezas-Herrera, José Neptuno Rodríguez-López |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14432-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival and Clinicopathological Significance of CD47 in Human Solid Tumors: An Updated Systematic Reviews and Meta‐Analysis
by: Yongzhi Ye, et al.
Published: (2025-08-01) -
Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression
by: Oanh T. P. Nguyen, et al.
Published: (2024-12-01) -
The role of CD47 in immune escape of colon cancer and its correlation with heterogeneity of tumor immune microenvironment
by: Qiu-Si Tian, et al.
Published: (2024-12-01) -
Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells
by: Susan N Christo, et al.
Published: (2024-01-01) -
The Prognostic Significance of CD47, CD68, and CD163 Expression Levels and Their Relationship with MLR and MAR in Locally Advanced and Oligometastatic Nasopharyngeal Carcinoma
by: Asim Armagan Aydin, et al.
Published: (2024-11-01)